D
Dima L. Diab
Researcher at University of Cincinnati
Publications - 23
Citations - 1924
Dima L. Diab is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Osteoporosis & Bone mineral. The author has an hindex of 13, co-authored 23 publications receiving 1598 citations. Previous affiliations of Dima L. Diab include University of Cincinnati Academic Health Center & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2016
Pauline M. Camacho,Steven M. Petak,Neil Binkley,Dima L. Diab,Leslie S. Eldeiry,Azeez Farooki,Steven T. Harris,Daniel L. Hurley,Jennifer J. Kelly,E. Michael Lewiecki,Rachel Pessah-Pollack,Michael R. McClung,Sunil J. Wimalawansa,Nelson B. Watts +13 more
TL;DR: A large number of the patients in this study had atypical femur fracture and the results confirmed the need for further investigation into the mechanisms leading to and effects of these fractures.
Journal ArticleDOI
Long-term use of bisphosphonates in osteoporosis.
Nelson B. Watts,Dima L. Diab +1 more
TL;DR: Bisphosphonates are popular and effective for treatment of osteoporosis and are recommended for a drug holiday after 5-10 yr of bisph phosphonate treatment.
Journal ArticleDOI
Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients
Dima L. Diab,Lisa Yerian,Philip R. Schauer,Sangeeta R. Kashyap,Rocio Lopez,Stanley L. Hazen,Ariel E. Feldstein +6 more
TL;DR: The potential utility of plasma caspase-generated cytokeratin 18 (CK-18) fragments as a novel marker for NAFLD before bariatric surgery is supported and the values with the best combination of sensitivity and specificity are supported.
Journal ArticleDOI
Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.
Sangeeta R. Kashyap,Dima L. Diab,Allison R. Baker,Lisa Yerian,Harpreet S. Bajaj,Courtney Gray-McGuire,Philip R. Schauer,Manjula K. Gupta,Ariel E. Feldstein,Stanley A Hazen,Catherine M. Stein +10 more
TL;DR: Both TG and ALT levels assist in identification of NASH in an obesity surgery cohort and underscore the importance of fatty acid delivery mechanisms to NASH development in severely obese individuals.
Journal ArticleDOI
Bisphosphonate drug holiday: who, when and how long:
Dima L. Diab,Nelson B. Watts +1 more
TL;DR: There is considerable controversy regarding the optimal duration of therapy and the length of the holiday, both of which should be based on individual assessments of risk and benefit.